ArticleFrontiers in immunology2024

Expert insights on Hodgkin's lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment.

Francesca Conti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.